Home > Healthcare > Biotechnology > Biopharma > Nucleotides Market

Nucleotides Market Share

Report ID: GMI7455
Published Date: Nov 2023
Report Format: PDF

Download Free Sample

Nucleotides Market Share

The nucleotides industry is characterized by the presence of several key players adopting technological advancements, research and development activities, and strategic initiatives:Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., and Agilent Technologies account for significant market share in the overall nucleotides market. They employ nucleotides in several applications such as pharmaceuticals, diagnostics, and biotechnology.

Market players operating in the nucleotides market are as mentioned below:

Nanjing Bio Together Co., Ltd.
Agilent Technologies
F. Hoffmann-La Roche Ltd. (CustomBiotech)
CJ CHEILJEDANG CORP.
DAESANG
Jena Bioscience GmbH
MEIHUA HOLDINGS GROUP CO. LTD
Promega Corporation
STAR LAKE BIOSCIENCE
Thermo Fisher Scientific Inc.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Nucleotides industry size was USD 588.4 million in 2022 and is expected to reach USD 1.1 billion by 2032 due to the rising demand for nucleotide-based therapeutics and increased research in genomics and molecular biology worldwide.

Nucleotides industry size from the diagnostic research segment recorded USD 382.4 million in 2022 and is expected to register appreciable CAGR from 2023-2032 owing to the ongoing advancements in nucleotide-based technologies.

North America nucleotides industry is expected to reach USD 420.2 million in revenue by 2032 due to the presence of leading biotechnology and pharmaceutical companies along with the availability of robust research infrastructure in the region.

Agilent Technologies, F. Hoffmann-La Roche Ltd. (CustomBiotech), CJ CHEILJEDANG CORP., DAESANG, Jena Bioscience GmbH, MEIHUA HOLDINGS GROUP CO. LTD, Promega Corporation, and STAR LAKE BIOSCIENCE are some of the major nucleotides companies worldwide.